| Literature DB >> 35466811 |
Nadia N Abuelezam1, Kristina L Greenwood2, Mawj Al-Ani3, Sandro Galea4, Raed Al-Naser5.
Abstract
OBJECTIVE: Little is known about risk factors associated with COVID-19 infection among Arab American people. We aimed to understand the predictors of receiving a positive COVID-19 test result and being admitted to the hospital for COVID-19 among Arab American adults using data from a hospital near an Arab ethnic enclave.Entities:
Keywords: Arab American; COVID-19; emerging infectious diseases; hospital; minority health
Mesh:
Year: 2022 PMID: 35466811 PMCID: PMC9066230 DOI: 10.1177/00333549221083740
Source DB: PubMed Journal: Public Health Rep ISSN: 0033-3549 Impact factor: 3.117
Characteristics of Arab American adults who were tested for COVID-19 or had admission data for COVID-19, Sharp Grossmont Hospital, La Mesa, California, March 1, 2020, through January 31, 2021
| Characteristics | Total (N = 2744) | Positive COVID-19 test result (n = 783) | Negative COVID-19 test result (n = 1961) | Total (n = 783) | Admitted (n = 131) | Not admitted (n = 652) |
|---|---|---|---|---|---|---|
| Age group, y | ||||||
| 18-29 | 590 (21.5) | 140 (17.9) | 450 (22.9) | 140 (17.9) | 2 (1.5) | 138 (21.2) |
| 30-49 | 921 (33.6) | 298 (38.1) | 623 (31.8) | 298 (38.1) | 22 (16.8) | 276 (42.3) |
| 50-69 | 726 (26.5) | 248 (31.7) | 478 (24.4) | 248 (31.7) | 49 (37.4) | 199 (30.5) |
| ≥70 | 507 (18.5) | 97 (12.4) | 410 (20.9) | 97 (12.4) | 58 (44.3) | 39 (6.0) |
| Sex | ||||||
| Male | 1266 (46.1) | 383 (48.9) | 883 (45.0) | 383 (48.9) | 68 (51.9) | 315 (48.3) |
| Female | 1478 (53.9) | 400 (51.1) | 1078 (55.0) | 400 (51.1) | 63 (48.1) | 337 (51.7) |
| Visit type | ||||||
| Inpatient | 896 (32.7) | 156 (19.9) | 740 (37.7) | NA | NA | NA |
| Outpatient/emergency | 1471 (53.6) | 603 (77.0) | 868 (44.3) | NA | NA | NA |
| Observation | 377 (13.7) | 24 (3.1) | 353 (18.0) | NA | NA | NA |
| Smoking status | ||||||
| Ever smoker | 618 (22.5) | 141 (18.0) | 477 (24.3) | 141 (18.0) | 22 (16.8) | 119 (18.3) |
| Never smoker | 1930 (70.3) | 600 (76.6) | 1330 (67.8) | 600 (76.6) | 89 (67.9) | 511 (78.4) |
| Missing | 196 (7.1) | 42 (5.4) | 154 (7.9) | 42 (5.4) | 20 (15.3) | 22 (3.4) |
| Marital status | ||||||
| Married | 1641 (59.8) | 491 (62.7) | 1150 (58.6) | 491 (62.7) | 77 (58.8) | 414 (63.5) |
| Single/widowed/separated/divorced | 1047 (38.2) | 271 (34.6) | 776 (39.6) | 271 (34.6) | 51 (38.9) | 220 (33.7) |
| Missing | 56 (2.0) | 21 (2.7) | 35 (1.8) | 21 (2.7) | 3 (2.3) | 18 (2.8) |
| Health insurance type | ||||||
| Private | 252 (9.2) | 79 (10.1) | 173 (8.8) | 79 (10.1) | 5 (3.8) | 74 (11.3) |
| Medi-Cal | 2056 (74.9) | 618 (78.9) | 1438 (73.3) | 618 (78.9) | 98 (74.8) | 520 (79.8) |
| Other public/other | 436 (15.9) | 86 (11.0) | 350 (17.8) | 86 (11.0) | 28 (21.4) | 58 (8.9) |
| Living in a zip code in which >12% of families live in poverty | 1590 (57.9) | 486 (62.1) | 1104 (56.3) | 486 (62.1) | 82 (62.6) | 404 (62.0) |
| % of Families in a zip code living in poverty, mean (SD) | 11.3 (3.5) | 11.4 (3.3) | 11.2 (3.6) | 11.3 (3.5) | 11.5 (3.3) | 11.4 (3.3) |
| Comorbidities | ||||||
| Obese | 218 (7.9) | 44 (5.6) | 174 (8.9) | 255 (32.6) | 62 (47.3) | 193 (29.6) |
| Chronic pulmonary disease | 952 (34.8) | 255 (32.6) | 697 (35.5) | 44 (5.6) | 14 (10.7) | 30 (4.6) |
| Diabetes without complications | 493 (18.0) | 151 (19.3) | 342 (17.4) | 151 (19.3) | 54 (41.2) | 97 (14.9) |
| Diabetes with complications | 154 (5.6) | 16 (2.0) | 138 (7.0) | 16 (2.0) | 12 (9.2) | 4 (0.6) |
| Hypertension | 761 (27.7) | 218 (27.8) | 543 (27.7) | 218 (27.8) | 73 (55.7) | 145 (22.2) |
| Charlson Comorbidity Index, mean (SD) | 2.6 (3.0) | 1.9 (2.1) | 2.9 (3.2) | 2.6 (3.0) | 4.3 (2.5) | 1.5 (1.7) |
| In-hospital mortality | 39 (1.4) | 22 (2.8) | 17 (0.9) | NA | NA | NA |
Abbreviation: NA, not applicable.
All data presented are number (percentage) unless otherwise indicated.
Bivariate and adjusted logistic regression models for receiving a positive test result (vs negative test result) for COVID-19 and being admitted to the hospital for COVID-19 among Arab American adults, Sharp Grossmont Hospital, La Mesa, California, March 1, 2020, to January 31, 2021
| Characteristic | Univariate OR (95% CI) | Full model, aOR (95% CI) |
|---|---|---|
|
| ||
| Sex | ||
| Female | 0.86 (0.73-1.01) | 0.77 (0.64-0.92)
|
| Male | 1 [Reference] | 1 [Reference] |
| Age, y | ||
| 18-29 | 1.32 (0.98-1.76) | 0.36 (0.21-0.60)
|
| 30-49 | 2.02 (1.56-2.62)
| 0.63 (0.39-1.00)
|
| 50-69 | 2.19 (1.68-2.87)
| 1.15 (0.81-1.63) |
| ≥70 | 1 [Reference] | 1 [Reference] |
| Marital status | ||
| Single/widowed/separated/divorced | 0.82 (0.69-0.97)
| 1.08 (0.88-1.32) |
| Married | 1 [Reference] | 1 [Reference] |
| Health insurance | ||
| Other public/other | 0.57 (0.44-0.74)
| 0.63 (0.45-0.86)
|
| Private | 1.06 (0.80-1.41) | 1.14 (0.83-1.56) |
| Medi-Cal | 1 [Reference] | 1 [Reference] |
| Months since March (time) | 1.33 (1.29-1.38)
| 1.34 (1.29-1.39)
|
| Living in a zip code in which >12% of families live in poverty | ||
| Yes | 1.24 (1.04-1.47)
| 1.25 (1.04-1.51) |
| No | 1 [Reference] | 1 [Reference] |
| Charlson Comorbidity Index | 0.92 (0.89-0.95)
| 0.83 (0.77-0.89)
|
|
| ||
| Sex | ||
| Female | 0.89 (0.60-1.26) | 0.64 (0.40-1.02) |
| Male | 1 [Reference] | 1 [Reference] |
| Age, y | ||
| 18-29 | 0.10 (0.01-0.04)
| 0.07 (0.01-0.44)
|
| 30-49 | 0.05 (0.03-0.10)
| 0.39 (0.13-1.18) |
| 50-69 | 0.17 (0.10-0.28)
| 0.36 (0.17-0.74)
|
| ≥70 | 1 [Reference] | 1 [Reference] |
| Marital status | ||
| Single/widowed/separated/divorced | 1.25 (0.84-1.84) | 2.03 (1.21-3.41)
|
| Married | 1 [Reference] | 1 [Reference] |
| Health insurance | ||
| Other public/other | 2.56 (1.55-4.22)
| 0.40 (0.20-0.81)
|
| Private | 0.36 (0.14-0.91)
| 0.61 (0.23-1.65) |
| Medi-Cal | 1 [Reference] | 1 [Reference] |
| Months since March (time) | 1.08 (1.00-1.17) | 1.02 (0.93-1.12) |
| Living in a zip code in which >12% of families live in poverty | ||
| Yes | 1.02 (0.69-1.50) | 0.88 (0.54-1.41) |
| No | 1 [Reference] | 1 [Reference] |
| Charlson Comorbidity Index | 1.87 (1.67-2.09)
| 1.66 (1.36-2.04)
|
Abbreviations: aOR, adjusted odds ratio; OR, odds ratio.
Using the Wald χ2 test, with P < .05 considered significant.